G-Con Manufacturing has announced a multi-million dollar investment by Pfizer Venture Investments (PVI).
Under terms of the agreement, Bill Burkoth from Pfizer Venture Investments will assume a position on G-Con’s board of directors.
G-Con and Pfizer will continue to work together in the Portable Continuous Miniature and Modular (PCMM) consortium with GEA Process Engineering to develop next-generation oral solid dosage processing technology that addresses rapidly changing requirements of pharmaceutical development and manufacturing.
G-CON Manufacturing president Maik Jornitz said: "We are very encouraged and motivated by this investment, which will accelerate G-CON’s already rapid growth."
Pfizer Venture Investments executive director Bill Burkoth said: "G-Con Manufacturing’s disruptive POD technology can change the pharmaceutical manufacturing landscape.
"The autonomous cleanroom PODs can be deployed quickly and easily, which allows manufacturers to distribute medicines at the time they are needed and also in smaller volumes."